Veru Inc. (NASDAQ:VERU) headquartered in Miami, will host a conference call for the investment community to discuss the 4Q20 financial results on 9th December 2020 at 8:00 AM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.verupharma.com
Veru Inc. is expected to report fourth quarter earnings results, before market open, on Wednesday 9th December 2020. Analysts polled by Thomson Reuters anticipate fourth quarter loss of $ 0.04 per share from revenue of $ 10.63 million. Looking ahead, the full year loss are expected at $ 0.15 per share on the revenues of $ 41.44 million.
Veru Inc. operates as an oncology and urology biopharmaceutical company. The company operates through two segments, Commercial, and Research and Development.